<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet patients have been studied, over a period of several months, by means of peroneal and median somatosensory- (SEP), brainstem auditory- (BAEP), and visual- (VEP) evoked potentials </plain></SENT>
<SENT sid="1" pm="."><plain>In both patients, peroneal SEP showed evidence of a pathological reduction in the central conduction velocity without a related deep sensation impairment, while VEP changes were consistent with the <z:e sem="disease" ids="C0042790" disease_type="Disease or Syndrome" abbrv="">visual disorders</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Conversely, BAEP and median SEP findings did not show disease-related abnormalities </plain></SENT>
<SENT sid="3" pm="."><plain>The observed anomalies were detectable irrespective of the clinical phase of the disease </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, evoked potential assessment is useful in providing objective evidence for evaluating and monitoring <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> damage in neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's syndrome </plain></SENT>
</text></document>